¹«ÓÃÔËÐй¤³Ìʦ н×ÊÃæÒé ÊÕ²Ø ÉêÇëְλ
Ê×Ò³ > Ì©ÖÝÕÐÆ¸ > ¹«ÓÃÔËÐй¤³Ìʦ

¹«ÓÃÔËÐй¤³Ìʦ

Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾

Ë¢ÐÂÓÚ£º2021-02-18±»ä¯ÀÀ£º808´Î

н×ÊÃæÒé

²»ÏÞ / ´óר / ÐÔ±ð²»ÏÞ / 2 / ²»ÏÞµ½¸Ú

½­ËÕ-Ì©ÖÝ £¨Ì©ÖÝÒ½Ò©¸ßм¼Êõ²úÒµÔ°¿Ú̩·Î÷²à½¼Ò·¶«²àG79´± £© Éϰà·Ïß²éѯ

ÕÐÆ¸2

³Â
ְλ·¢²¼ÈË£º³ÂÏÈÉú

139****6549,052****713092 ÏÔʾºÅÂë

(ÁªÏµÊ±Çë˵Ã÷ÊÇÔÚÐÂÌ©ÖÝÈ˲ÅÍøÉÏ¿´µ½µÄ)

´òµç»°Ç°ÏÈͶ¸ö¼òÀú£¬»ñµÃÃæÊԵijɹ¦ÂÊÔö¼Ó30%

Ì©ÖÝÈ˲ÅÍøÌáʾ£ºÌ©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾ÎÞȨÊÕÈ¡ÈκηÑÓã¬Çë¹ã´óÇóÖ°Õß¼ÓÇ¿×ÔÎÒ±£»¤Òâʶ£¬°´ÀͶ¯·¨¹æ±£»¤×ÔÉíÈ¨Òæ£¬¾¯ÌèÐé¼ÙÕÐÆ¸,±ÜÃâÉϵ±ÊÜÆ­£¡ ¾Ù±¨´Ëְλ
ְλÃèÊö

1¸ºÔð¶½´Ù¹«ÓÃϵͳÔËÐÐÔ±×ñÊØ¸÷Ïî¹æÕÂÖÆ¶¨Ñϸñ°´¸ÚλSOP²Ù×÷£¬¼°Ê±×¼È·ÈçʵµØÌîд¼Ç¼ÄÚÈÝ£¬¼°Ê±»ã×ÜÉóºË²¢Ç©×ÖÈ·ÈÏ£»

2¸ù¾ÝÖ÷¹ÜÖÆ¶¨µÄά±£¼Æ»®ÊµÊ©£¬±£Ö¤É豸µÄÍêºÃÂÊ£»

ЭÖúÍê³É¸ÚλÉ豸ÉèÊ©µÄ¼¼Êõ¸ÄÔ죬Ìá¸ßÉ豸ÉèÊ©ÐÔÄÜ£»

²ÎÓëÍê³É¸ÚλÉ豸ÉèÊ©µÄÈ·ÈϹ¤×÷£¬È·ÈÏÉ豸ÉèÊ©µÄÓÐЧÐÔ£»

3¼°Ê±×öºÃ¸ÚλÖÊÁ¿¼à¿Øµã°²È«Òþ»¼µãµÄ¼ì²é¹¤×÷£¬¶¨ÆÚ¿ªÕ¹×Ô¼ìµÈ¹¤×÷£¬ÌáÉý¸Úλ5S¼°GMP¹ÜÀíˮƽ£»

4ЭÖú¼ÆÁ¿¹¤³Ìʦ¼ÆÁ¿Ïà¹Ø¹¤×÷£¬±£Ö¤±¾°à×éËùÓÃÒÇÆ÷ÒDZí·ûºÏ¼ÆÁ¿ÒªÇó£¬ÄÜÔ´¼ÆÁ¿ÒDZíÍêºÃ׼ȷ£»

5¸ºÔð¶ÔÉ豸ÔËÐйý³ÌÖгöÏֵĹÊÕϽøÐд¦Àí¡£
µ±É豸·¢Éú¹ÊÕÏʱ£¬Ñ¸Ëٸϸ°É豸ÏÖ³¡£
¬¸ù¾Ý¹ÊÕÏÏÖÏ󣬷ÖÎöÅжϳö¹ÊÕÏÔ­Òò£¬²¢Õë¶Ô¹ÊÕÏÔ­ÒòʵʩÓÐЧµØÎ¬ÐÞ´¦Àí£¬Í¬Ê±¶ÔÉ豸¹ÊÕϵãÏà¹Ø²¿Î»½øÐи½´ø¼ì²é£¬·ÀÖ¹ÒÅ©ÆäËûʹÊÒþ»¼£¬È·ÈϹÊÕÏÅųýºó£¬½»Óɼ¼ÊõÔ±Æô¶¯É豸£¬´ýÉ豸ÔËÐÐÕý³£ºó£¬·½¿É³·ÀëÏÖ³¡£
»6°´ÒªÇó×öºÃ°²È«Òþ»¼µÄÅŲ飬×öºÃ×ÔÉí°²È«·À»¤¹¤×÷£¬±ÜÃⰲȫ¼°ÖÊÁ¿Ê¹ʵķ¢Éú£»

7ÊáÀí¹«ÓÃÉèÊ©µÄ±¸¼þµÄ¿â´æ£¬Ã¿Ô¸ù¾Ýʵ¼ÊÇé¿öÉ걨²É¹º¼Æ»®£¬±£Ö¤ÁãÅä¼þÆëÈ«£¬¿â´æºÏÀí£¬¶Å¾øÀË·ÑÏÖÏó£»

8ЭÖú¹«ÓÃÉèÊ©¹ÜÀíÖÆ¶È¼°Ïà¹ØÉ豸SOPµÄÖÆ¶¨ÓëÐÞ¶©£¬¹æ·¶Ô±¹¤ÈÕ³£ÐÐΪ²¢×öºÃÔ±¹¤ÈÕ³£ÐÐΪµÇ¼Ç¹¤×÷£»

9¸ºÔðЭµ÷¸Úλ¸÷Ïî¼ì²â¹¤×÷µÄ¿ªÕ¹£¬¹Ø×¢½éÖʶ¯Ì¬ÖÊÁ¿¡£
ÈÎÖ°ÒªÇó£º1ÖÆÒ©ÆóÒµ¹«ÓÃϵͳάÐÞ¹ÜÀí¾­Ñé5ÄêÒÔÉÏ£»

2ÊìϤGMP֪ʶ£»

3ÓÐÖÆÒ©ÆóÒµ¹«ÓÃϵͳGMP¼ì²é¾­Ñé¡£

¹«Ë¾¼ò½é
Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾ÓÚ2015ÄêÈëפ̩ÖÝÊÐÖйúÒ½Ò©³Ç£¬×¢²á×ʱ¾2000ÍòÃÀÔª¡£¹«Ë¾Ö÷Òª´Óʵ¥¿¹Ò©ÎïÉú²ú£¬Í¶×Ê×ܶî2ÒÚÃÀÔª£¬Ä⽨³§·¿Ãæ»ý3ÍòÓàÆ½·½£¬½¨Éè·ûºÏGMP±ê×¼µÄ¹ú¼ÊÏȽøµÄ¿¹ÌåÒ©ÎïÖÆ±¸Ìåϵ£¬ÒÔÆÚ´òÔì¹úÄÚ¿¹ÌåÒ©ÎïÉú²ú¸ßµØ¡£Âõ²©Ì«¿ÆÒ©ÒµÓÉÉϺ£ÕŽ­ÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾£¨¿¹ÌåÒ©ÎïÓë°ÐÏòÖÎÁƹú¼ÒÖØµãʵÑéÊÒ£©¿¹ÌåÑз¢ÍŶÓÌṩһվʽƽ̨·þÎñ£¬ÖÂÁ¦ÓÚʵÏÖһϵÁÐÖØÁ¿¼¶¹ú¼Ò´´Ð¿¹ÌåÒ©ÎïµÄ²úÒµ»¯¡£ÏÖÓÐÆ·ÖÖ£ºÖÎÁƽáÖ±³¦°©µÄÖØ×鿹EGFRÈËÊóǶºÏµ¥¿Ë¡¿¹Ì壬ÖÎÁÆÒøÐ¼²¡µÄÖØ×éÈËLFA3-¿¹ÌåÈںϵ°°×µÈ¡£TaizhouMabtechPharmaceuticalCo.,Ltd.joinedtheChinaMedicalCity(CMC)in2015withregisteredcapitalofUSD20million,expandinganationalhighlandformonoclonalantibodymedicinemanufacturingbyestablishinginternationallyadvancedantibodymedicinemanufacturesystemwithadoptedcGMPstandards,withatotalinvestmentofUSD200million.Supportedbytheone-stopplatformfortherapeuticmAbmedicinedevelopmentprovidedbyZJ-BioR&DTeam(StateKeyLaboratoryofAntibodyMedicineandTargetedTherapy),TaizhouMabtechPharmaceuticsCo.,Ltdisdedicatedtoindustrializationofaseriesof¡°blockbuster¡±innovativeantibodydrugs.Existingvarieties:recombinantanti-EGFRhuman/mouse-chimericmonoclonalantibodyforthetreatmentofcolorectalcancer,recombinanthumanLFA3-antibodyfusionproteinforthetreatmentofpsoriasis,etal.
¸Ã¹«Ë¾µÄÆäTAְλ
Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾
  • ÖÆÔìÒµ
  • ÍâÉÌͶ×ÊÆóÒµ
  • ½­ËÕ-Ì©ÖÝ
  • 100-1000ÈË
0%¼òÀú·´À¡ÂÊ
0ƽ¾ù»Ø¸´Ê±³¤
0¸öÕÐÆ¸Ö°Î»
ְλÃû³Æ£º¹«ÓÃÔËÐй¤³Ìʦ
¹«Ë¾Ãû³Æ£º Ì©ÖÝÂõ²©Ì«¿ÆÒ©ÒµÓÐÏÞ¹«Ë¾
 
ÏàËÆÖ°Î»
  • ¹¤³Ìʦ
    ÃæÒé Ì©ÖÝ-Ì©ÐË
    ½­ËÕÁªÊ¢±£°²·þÎñÓÐÏÞ¹«Ë¾